Companies / Kenya
Regulatory Lags Hold Back Drug Approvals
May 2008 | Industry NewsKenya's drug approvals process has come under fire after the Kenya Medical Research Institute (KEMRI) claimed that the country lacks the capacity to approve, register and review applications for new drugs. As a consequence, Kenya is reliant on foreign institutions to guide its approvals
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
